Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Robert H. Lurie Comprehensive Cancer Center of Northwestern University · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · +39 more institutions
Abstract
Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the United States and is the country's fifth most common cause of cancer mortality in women. A major challenge in treating ovarian cancer is that most patients have advanced disease at initial diagnosis. These NCCN Guidelines discuss cancers originating in the ovary, fallopian tube, or peritoneum, as these are all managed in a similar manner. Most of the recommendations are based on data from patients with the most common subtypes─high-grade serous and grade 2/3 endometrioid. The NCCN Guidelines also include recommendations specifically for patients with less common ovarian cancers, which in the guidelines include the following:…
Citation impact
- FWCI
- 106.94
- Percentile
- 100%
- References
- 583
Authors
35- WJWilliam J. GradisharCorresponding
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- BOBenjamin O. Anderson
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa, Seattle Cancer Care Alliance, Fred Hutch Cancer Center, Cancer Research Center
- JAJame Abraham
Cleveland Clinic, Cancer Institute (WIA), University Hospitals Seidman Cancer Center
- RARebecca Aft
Barnes-Jewish Hospital, Jewish Hospital
- DMDoreen M. Agnese
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Topics & keywords
- Medicine
- Oncology
- Breast cancer
- Clinical Oncology
- Internal medicine
- Cancer
- Clinical Practice
- Metastatic breast cancer
- Good health and well-being